Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the journal mBio.
Moderna strikes $1.8B cancer research deal with Immatics
Moderna has inked a deal worth up to $1.8 billion with TCR specialist Immatics that broadens the company’s position in mRNA-based cancer research. The Cambridge,